Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.99 USD | -1.32% | -3.39% | +22.49% |
05-17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
05-13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CAPRICOR THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.32% | -3.39% | +22.49% | +28.82% | +112.34% | 189M |
- Stock Market
- Equities
- CAPR Stock
- Charts Capricor Therapeutics, Inc.
- Relative Strength Chart